DEFC14A: Carronade Launches Proxy Battle for Cannae Board Seats

Sentiment:

Shareholder Proxy Solicitation


Activist investor Carronade Capital is soliciting proxies to elect four independent directors to Cannae Holdings' board, citing prolonged share price underperformance, poor governance, and misaligned management compensation.

Delay expectedThe company significantly delayed its 2025 Annual Meeting of Shareholders, scheduling it for December 12, 2025, which is more than 175 days after the anniversary date of the 2024 Annual Meeting (June 19, 2024).Carronade Capital believes this delay reflects a blatant disregard for commonly accepted corporate governance principles and is a consequence of the Board's decision to reincorporate from Delaware to Nevada.
Worse than expectedThe filing details Cannae's prolonged share price underperformance, lagging behind relevant benchmarks and peers by significant margins (e.g., 229% over five years).The company trades at a persistent and substantial discount to its Net Asset Value (NAV), averaging -37% over three years, indicating a market valuation significantly below the intrinsic value of its assets.Management compensation totaling over $650 million since 2017 is highlighted as burdensome and misaligned with the company's annualized Total Shareholder Return (TSR) of only 0.4% since inception.The filing points to severely deficient corporate governance practices, including a lack of true Board independence and actions taken by the Board (e.g., changes to Mr. Foley's employment agreement and director equity awards) that are perceived as entrenching management at shareholders' expense.

Summary

  • Carronade Capital Master, LP and its affiliates beneficially own approximately 3.2 million shares (6.2%) of Cannae Holdings, Inc. common stock, making them one of the company's largest shareholders.
  • Carronade has nominated four highly qualified, independent director candidates—Mona Aboelnaga, Benjamin C. Duster, IV, Dennis A. Prieto, and Chrie L. Schaible—for election at Cannae's 2025 Annual Meeting of Shareholders.
  • The Annual Meeting is scheduled to be held virtually on December 12, 2025.
  • Carronade believes significant changes to the Board are necessary to address prolonged share price underperformance, a persistent valuation discount, poor corporate governance, and ineffective Board oversight.
  • Key issues highlighted include burdensome management compensation totaling over $650 million since 2017, an ineffective and unclear corporate strategy, and severely deficient corporate governance with a lack of Board independence.
  • Carronade intends to vote its shares FOR its nominees, AGAINST the company's advisory proposal on executive compensation, FOR the ratification of Grant Thornton LLP as the independent auditor, FOR the declassification proposal, and FOR the shareholder investment banker proposal.
  • The Carronade nominees collectively possess deep expertise in corporate governance, financial and legal oversight, investment management, restructuring, and capital allocation.
  • Carronade is urging shareholders to use the GOLD universal proxy card to vote for its nominees and against the incumbent management slate.

Sentiment

Score: 3

Explanation: The sentiment is predominantly negative due to Carronade Capital's strong criticisms of Cannae's underperformance, excessive management compensation, and poor corporate governance. While Carronade believes in the underlying asset value, the current state of the company and its leadership is presented as highly problematic, necessitating a proxy fight for change.

Positives

  • Carronade Capital believes in the inherent value embedded in Cannae's portfolio of assets and sees a significant opportunity for value creation.
  • The company has announced an increase in share repurchase authorization and an intent to use at least $460 million from the Dun & Bradstreet (DNB) sale proceeds for share repurchases, dividends, and debt retirement.
  • Cannae has committed to migrating to annual election of directors on a phased basis, which Carronade views as directionally positive, though insufficient.
  • The company appointed two new independent directors, William T. Royan and Woodrow Tyler, effective June 1, 2025, although without Carronade's input.

Negatives

  • Cannae has suffered from prolonged share price underperformance and a persistent valuation discount, with its equity trading at an average discount to NAV per share of -37% over the past three years.
  • Management compensation has totaled over $650 million since 2017, which Carronade views as burdensome and misaligned with the company's annualized Total Shareholder Return (TSR) of 0.4%.
  • The company's TSR has underperformed disclosed proxy peers by 229%, -69%, and -51% over five-, three-, and one-year periods, respectively, prior to Carronade's public engagement.
  • Carronade criticizes an ineffective and unclear corporate strategy, including a lack of strategic cohesion amongst investments and limited portfolio company disclosure, particularly regarding investments in small private positions.
  • Corporate governance is deemed severely deficient, with a pattern of interconnectedness among current and previous directors and executives, undermining shareholder confidence.
  • The Board's actions on March 17, 2025, including accelerating equity vesting for directors if not re-elected and a provision for Mr. Foley's share repurchase at a premium if he resigned for 'Good Reason' (including election of a director he didn't support), are highlighted as egregious.
  • The company significantly delayed the 2025 Annual Meeting, holding it more than 175 days after the anniversary of the 2024 meeting, which Carronade views as a disregard for corporate governance principles.
  • Mr. Foley received an egregious severance payout of $3,000,000 (base salary) and $14,196,000 (bonus) upon his transition to non-executive Vice Chairman, along with accelerated vesting of equity awards and an extended right to sell shares back to the company at a premium.

Risks

  • Prolonged share price underperformance and persistent valuation discount due to current management and board oversight.
  • Risk of continued misaligned management compensation impacting shareholder returns.
  • Ineffective corporate strategy and capital allocation priorities leading to poor investment outcomes.
  • Conflicts of interest arising from interconnectedness among current and previous directors and executives, potentially compromising objective decision-making.
  • Lack of true Board independence hindering accountability to shareholders.
  • Potential for further entrenchment of leadership at the expense of shareholders through reactive measures.
  • Negative market reaction to company announcements, as evidenced by share price drops following material updates.

Future Outlook

Carronade Capital believes Cannae has the potential to unlock substantial value through straightforward improvements in strategy and governance. If elected, the Carronade Nominees are prepared to work constructively with the Board to identify and unlock opportunities to improve performance, ensure accountability, and drive shareholder value creation. Their plans include reducing costs, aligning incentives, improving transparency to shareholders, and evaluating Board and committee leadership.

Management Comments

  • Carronade Capital: "We strongly believe that there is a significant opportunity for value creation."
  • Carronade Capital: "Meaningful change is required on the Board in order to establish accountability to shareholders and unlock the Companys trapped potential."
  • Carronade Capital: "We are interested in working with the Company privately and constructively to address these issues and assist in positioning the Company towards growth going forward."
  • Carronade Capital: "We believe that by adding new and experienced independent directors, the Company will be able to lay the foundation needed to re-build investor confidence and enhance shareholder value."
  • Carronade Capital: "The Boards March 17th actions, together with the limited engagement on the critical governance concerns, demonstrated a lack of willingness to meaningfully engage in good faith settlement discussions."
  • Carronade Capital: "The moves were directionally positive, but insufficient to address the Companys persistent underperformance and history of poor corporate governance practices."
  • Carronade Capital: "The Boards delay in timely holding the Annual Meeting reflects a blatant disregard for commonly accepted corporate governance principles."
  • Carronade Capital: "We firmly believe in the inherent value embedded in the Companys portfolio of assets."
  • Carronade Capital: "We believe meaningful change is required to substantially improve shareholder value, and that the factors driving Cannaes persistent underperformance are clear."
  • Carronade Capital: "We believe management compensation needs to be streamlined and more appropriately aligned with performance to reflect best-in-class practices."
  • Carronade Capital: "Cannae shareholders deserve increased transparency and a strategy that focuses on unlocking the valuable aspects of the portfolio."
  • Carronade Capital: "A reconstituted Board with truly independent directors is required to instill accountability in the boardroom."
  • Carronade Capital: "The Company has been unwilling to address the level of change that we believe is required to put Cannae on a better path forward, opting to instead take several reactive measures designed to maintain the status quo."
  • Carronade Capital: "We believe shareholders deserve a Board that demands accountability and is committed to taking proactive measures with the best interests of shareholders in mind at all times."

Industry Context

Cannae Holdings operates in an environment where investor confidence is tied to clear strategic execution, transparent capital allocation, and robust corporate governance. The persistent valuation discount and underperformance relative to both disclosed proxy peers (e.g., MAIN, CODI, STEP, HTGC, FHI, CSWC, APAM, TRIN, HLNE, BRDG, GCMG) and closed-end fund peers (e.g., UTG, STEW, KYN, CET, GAM, IGR, EOI, MEGI, PEO) suggest that Cannae is failing to meet industry expectations for value realization from its asset portfolio. The market's lack of confidence, particularly after significant asset monetizations like the DNB IPO and Dayforce sell-down, indicates a disconnect between the company's asset value and its market capitalization, a common challenge for holding companies with opaque strategies or governance issues.

Comparison to Industry Standards

  • Cannae's Total Shareholder Return (TSR) of 0.4% since inception as an independent public entity is significantly below industry benchmarks, especially when contrasted with the over $650 million in management compensation during a similar period.
  • The company's TSR has underperformed its disclosed proxy peers (MAIN, CODI, STEP, HTGC, FHI, CSWC, APAM, TRIN, HLNE, BRDG, GCMG) by 229% over five years, -69% over three years, and -51% over one year, indicating severe underperformance against comparable investment firms.
  • Cannae trades at an average discount to its Net Asset Value (NAV) per share of -37% over the past three years, placing its current discount in the bottom two of over 200 US investment firms with assets over $500 million, suggesting a significant market skepticism compared to industry norms.
  • The company's classified Board structure and perceived lack of independence, with directors having long-standing affiliations with former CEO William Foley's other business interests (e.g., Fidelity National Financial, Black Knight Sports and Entertainment, various SPACs), deviate from best-in-class corporate governance practices that emphasize independent oversight.
  • The Board's actions, such as accelerating equity vesting for directors not re-elected and providing premium share repurchase rights to Mr. Foley contingent on board composition, are seen as highly unusual and contrary to shareholder-aligned compensation and governance standards, drawing adverse voting recommendations from leading proxy advisory firms.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer, Chief Investment Officer, Chairman of the BoardWilliam FoleyRyan Caswell (CEO), Doug Ammerman (Chairman)May 12, 2025Transition to non-executive Vice Chairman for Mr. Foley; part of company's response to activist pressure and internal restructuring.
Chairman of the BoardWilliam FoleyDoug AmmermanMay 12, 2025Part of Mr. Foley's transition and company restructuring.
Non-executive Vice Chairman of the BoardN/AWilliam FoleyMay 12, 2025Transition from executive roles.
DirectorN/AWilliam T. RoyanJune 1, 2025Company appointment, made without Carronade Capital's input.
DirectorN/AWoodrow TylerJune 1, 2025Company appointment, made without Carronade Capital's input.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionCarronade Capital is seeking to elect four independent directors to replace four incumbent Class II directors, aiming to enhance independence and accountability.Upon election at 2025 Annual MeetingExpected to bring fresh perspectives, objectivity, and a shareholder voice to the Board, potentially improving oversight and strategic decision-making.
Board DeclassificationThe company is seeking shareholder approval to amend its Articles of Incorporation to declassify the Board over a three-year period, resulting in annual election of all directors starting at the 2028 Annual Meeting.Phased implementation starting 2026 Annual Meeting, fully effective 2028 Annual Meeting (if approved)Carronade believes annual election of directors is critical for promoting and maintaining board and management accountability, aligning with corporate governance best practices, though they advocate for an accelerated declassification.
Executive Compensation StructureThe Board approved an amended employment agreement for William Foley, including a provision for the company to repurchase 50% of his shares at a premium if he resigns for 'Good Reason' (including election of a director he does not support).March 17, 2025 (amendment), January 2026 (repurchase right)Carronade views this as an egregious action designed to entrench leadership and misalign incentives, potentially hindering shareholder value creation.
Director Equity Incentive AwardsThe Board approved a change to terms of director equity incentive awards, providing for immediate vesting of outstanding and unvested restricted stock and equity awards if any director is not reelected by shareholders.March 17, 2025Carronade views this as an action designed to entrench incumbent directors and undermine shareholder voting power, creating a 'golden parachute' for directors who fail to secure re-election.
Annual Meeting TimingThe company significantly delayed the 2025 Annual Meeting, holding it more than 175 days after the anniversary of the previous year's meeting.August 26, 2025 (announcement of date)Carronade views this as a blatant disregard for commonly accepted corporate governance principles and a tactic to maintain the status quo, potentially limiting shareholder engagement and accountability.

Related Party Transactions

  • Management directed Cannae shareholder capital into unsuccessful SPAC investments sponsored by Trasimene Capital Management, LLC, which previously managed Cannae and is controlled by former CEO and Chairman Foley, creating clear conflicts of interest and bestowing windfall sponsor economics on entities outside of Cannae.
  • Management's history of selling personally-owned shares in portfolio companies ahead of Cannae selling those shares, including Mr. Foley and Mr. Coy selling approximately 5 million shares of Alight, Inc. on November 13, 2024, before Cannae sold 12 million shares on December 3, 2024.
  • Mr. Foley selling 2.5 million shares of Dun & Bradstreet (DNB) on March 25, 2025, the same day Cannae announced its ability to sell up to 10 million shares as part of a Voting Support Agreement for DNB's take-private transaction.
  • The amended and restated employment agreement for Mr. Foley, approved by the Compensation Committee and Related Person Transaction Committee, included a provision requiring the company to repurchase 50% of his shares at a premium if he resigns for 'Good Reason', including if any director is elected without his support.
  • Changes to director equity incentive awards, approved by the Compensation Committee and Related Person Transaction Committee, providing for immediate vesting if any director is not reelected by shareholders.
  • The high degree of interconnectedness amongst current directors, including with other business interests of Mr. Foley (e.g., Fidelity National Financial, Black Knight Sports and Entertainment LLC, various SPACs), which Carronade believes undermines their ability to act objectively and threatens Board independence.

Stakeholder Impact

  • **Shareholders:** Expected to benefit from improved share price performance and value creation if Carronade's nominees are elected and their proposed governance and strategic changes are implemented. Currently negatively impacted by prolonged underperformance, valuation discount, and perceived poor governance.
  • **Management:** Current management faces scrutiny and potential replacement or reduced influence if Carronade's nominees are elected. Existing compensation structures are criticized as burdensome and misaligned with shareholder returns.
  • **Board of Directors:** The composition and independence of the Board are directly challenged. Election of Carronade's nominees would alter the Board's dynamics and potentially lead to a more independent and accountable oversight body.
  • **Employees:** Not directly addressed, but changes in corporate strategy and cost reduction efforts could indirectly impact employees.
  • **Creditors:** The company's intent to retire existing debt using proceeds from the DNB sale could positively impact creditors by reducing leverage.

Next Steps

  • Shareholders will vote on the election of directors at the 2025 Annual Meeting on December 12, 2025.
  • Shareholders will also vote on an advisory basis for executive compensation, ratification of the independent auditor, declassification of the Board, and a shareholder proposal to engage an investment banker.
  • If elected, Carronade Nominees will seek to work with other Board members to enhance shareholder value, including by reducing costs, aligning incentives, improving transparency, and evaluating Board and committee leadership.
  • Carronade Capital intends to seek reimbursement from the Company for all expenses incurred in connection with this solicitation.

Key Dates

DateDescription
2017Start of period for calculating burdensome management compensation ($650 million since 2017).
2019IPO of Dun & Bradstreet (DNB), after which Cannae's discount to NAV persistently widened.
2020Start of period for sell down of Dayforce, Inc. (formerly Ceridian HCM Holding Inc.) through 2023.
2023Cannae's 2023 Annual Meeting of Shareholders (Class III directors elected for three-year term).
June 19, 2024Cannae's 2024 Annual Meeting of Shareholders was held.
September 6, 2024Carronade Capital Master, LP purchased 1,000 shares of Common Stock.
September 19, 2024Carronade Capital Master, LP purchased 100,000 shares of Common Stock.
September 20, 2024Carronade Capital Master, LP purchased 300,000 shares of Common Stock (two transactions).
September 23, 2024Carronade Capital Master, LP purchased 50,000 shares of Common Stock.
September 25, 2024Carronade Capital Master, LP purchased 153,263 shares of Common Stock.
October 1, 2024Carronade Capital Master, LP purchased 59,121 shares of Common Stock.
October 2, 2024Carronade Capital Master, LP purchased 40,000 shares of Common Stock.
October 3, 2024Carronade Capital Master, LP purchased 75,000 shares of Common Stock.
October 17, 2024Carronade Capital Master, LP purchased 50,000 shares of Common Stock.
October 18, 2024Carronade Capital Master, LP purchased 100,000 shares of Common Stock.
October 21, 2024Carronade Capital Master, LP purchased 44,542 shares of Common Stock.
October 22, 2024Carronade Capital Master, LP purchased 50,000 shares of Common Stock.
October 24, 2024Carronade Capital Master, LP purchased 40,000 shares of Common Stock.
October 25, 2024Carronade Capital Master, LP purchased 70,000 shares of Common Stock.
October 29, 2024Carronade Capital Master, LP purchased 150,000 shares of Common Stock.
October 30, 2024Carronade Capital Master, LP purchased 1,000 shares of Common Stock.
October 31, 2024Carronade Capital Master, LP purchased 125,000 shares of Common Stock.
November 1, 2024Carronade Capital Master, LP purchased 60,000 shares of Common Stock.
November 12, 2024Carronade Capital Master, LP purchased 100,000 shares of Common Stock.
November 13, 2024Mr. Foley and Mr. Coy sold approximately 5 million shares of Alight, Inc.; Carronade Capital Master, LP purchased 60,000 shares of Common Stock.
December 3, 2024Cannae sold 12 million shares of Alight, Inc.
December 4, 2024Carronade Capital Management, LP (Managed Account) purchased 55,787 shares of Common Stock.
December 19, 2024Carronade Capital sent a private letter to the Board outlining investment perspectives and notifying of director nominations; delivered Initial Nomination Notice.
December 20, 2024Mr. Gravelle confirmed receipt of Carronade's letter and nomination notice.
December 23, 2024Dennis A. Prieto purchased 820 shares of Common Stock.
December 27, 2024Company's early nomination deadline.
January 3, 2025Carronade Capital Management, LP (Managed Account) purchased 28,920 shares of Common Stock.
January 6, 2025Mona Aboelnaga purchased 800 shares of Common Stock.
January 10, 2025Benjamin C. Duster, IV purchased 1,338.329 shares of Common Stock.
January 13, 2025Chrie L. Schaible purchased 1,360 shares of Common Stock.
January 21, 2025Carronade Capital sent a follow-up email requesting an in-person meeting; Mr. Foley responded he would be in Hawaii.
January 23, 2025Mr. Gravelle suggested a Teams call with Mr. Caswell and Mr. Coy as a first step.
January 31, 2025Carronade Capital spoke with Mr. Caswell and Mr. Coy, reiterating interest in collaboration and requesting an in-person meeting.
February 1, 2025Start of period Carronade Capital was prepared to travel for a meeting (until February 21, 2025).
February 7, 2025Carronade Capital Master, LP purchased 47,631 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 2,369 shares of Common Stock.
February 18, 2025Mr. Gravelle emailed Carronade Capital offering a call with Mr. Foley and Mr. Caswell; Carronade Capital Master, LP purchased 47,631 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 2,369 shares of Common Stock.
February 19, 2025Carronade Capital responded, reiterating preference for an in-person meeting.
February 20, 2025Mr. Gravelle responded that the Company did not believe an in-person meeting was necessary; Carronade Capital Master, LP purchased 84,784 shares of Common Stock (two transactions); Carronade Capital Management, LP (Managed Account) purchased 4,216 shares of Common Stock (two transactions).
February 25, 2025Carronade Capital had a call with Mr. Foley and Mr. Caswell, sharing a presentation on underperformance and value creation steps.
February 26, 2025Carronade Capital Master, LP purchased 238,157 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 11,843 shares of Common Stock.
February 27, 2025Carronade Capital Master, LP purchased 204,906 shares of Common Stock (two transactions); Carronade Capital Management, LP (Managed Account) purchased 10,194 shares of Common Stock (two transactions).
February 28, 2025Carronade Capital Master, LP purchased 41,217 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 2,050 shares of Common Stock.
March 3, 2025Carronade Capital Master, LP purchased 66,706 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 3,294 shares of Common Stock.
March 4, 2025Carronade Capital Master, LP purchased 64,032 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 3,162 shares of Common Stock.
March 5, 2025Carronade Capital emailed Mr. Foley, Mr. Caswell, and Mr. Gravelle requesting a call by March 7, 2025.
March 6, 2025Carronade Capital Master, LP purchased 79,493 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 3,930 shares of Common Stock.
March 7, 2025Carronade Capital Master, LP purchased 69,194 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 3,449 shares of Common Stock.
March 10, 2025Carronade Capital had a call with Mr. Caswell to discuss Cannae's feedback; Carronade Capital Master, LP purchased 82,224 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 4,063 shares of Common Stock.
March 12, 2025Carronade Capital had a call with Mr. Caswell to discuss critical drivers of value and capital return.
March 13, 2025Carronade Capital had a call with Mr. Caswell to discuss necessary changes and followed up with an email outlining a proposal.
March 17, 2025Carronade Capital had a call with Mr. Caswell; after market close, Cannae filed Form 8-K disclosing amended employment agreement for Mr. Foley and changes to director equity incentive awards.
March 18, 2025Carronade Capital had a call with Mr. Caswell outlining governance changes and expressing concerns about March 17th actions.
March 19, 2025Mr. Caswell responded to Carronade's proposed governance changes; Carronade expressed belief in lack of good faith engagement.
March 20, 2025Carronade Capital issued a press release and public letter; Cannae issued a press release in response; Carronade Capital Master, LP purchased 119,115 shares of Common Stock; Carronade Capital Management, LP (Managed Account) purchased 5,885 shares of Common Stock.
March 25, 2025Cannae announced support for the sale of Dun & Bradstreet (DNB), increased share repurchase authorization, and intent to migrate to annual election of directors; Mr. Foley sold 2.5 million shares of DNB.
March 27, 2025Carronade Capital had a call with Mr. Caswell to discuss recent company actions, deeming them directionally positive but insufficient.
March 28, 2025Carronade Capital had a call with Mr. Caswell, who suggested interviewing Carronade Nominees without committing to governance changes.
March 31, 2025Cannae announced intent to use at least $460 million from DNB sale proceeds for share repurchases, dividends, and debt retirement; Carronade Capital sent an email reiterating nominee qualifications and willingness to interview upon resolution of Board change.
April 1, 2025Carronade Capital Management, LP (Managed Account) purchased 35,278 shares of Common Stock.
April 3, 2025Carronade Capital delivered a Books and Records Request to the Company.
April 7, 2025Carronade Capital filed its preliminary proxy statement with the SEC; Mr. Caswell reiterated interest in interviewing Carronade Nominees.
April 8, 2025The Company responded to the Books and Records Request; Carronade Capital responded to Mr. Caswell, expressing concern about bad faith negotiations.
April 25, 2025Carronade Capital filed amendment no. 1 to its preliminary proxy statement with the SEC.
April 28, 2025Dennis A. Prieto purchased 650 shares of Common Stock.
April 30, 2025Carronade Capital had a call with Mr. Caswell, who stated Cannae identified and would appoint two new independent director candidates.
May 2, 2025Carronade Capital responded to Mr. Caswell, stating the proposal did not accomplish the needed governance change.
May 12, 2025Company announced Mr. Foley's transition to non-executive Vice Chairman, Doug Ammerman's appointment as Chairman, and Mr. Caswell's appointment as CEO; company also announced appointment of William T. Royan and Woodrow Tyler as new directors, effective June 1, 2025.
May 13, 2025Cannae's share price dropped -5% following material updates to the market.
June 1, 2025Effective date for appointment of William T. Royan and Woodrow Tyler as new directors.
June 2, 2025Carronade Capital Master, LP purchased 69,051 shares of Common Stock.
June 3, 2025Carronade Capital Master, LP purchased 69,051 shares of Common Stock.
June 9, 2025Carronade Capital filed a Schedule 13D disclosing a 5.2% ownership position and the Initial Nomination Notice.
June 23, 2025Carronade Capital issued a press release calling on the Company to promptly announce the date of the Annual Meeting.
August 8, 2025BlackRock, Inc. filed its Schedule 13F.
August 11, 2025Carronade Capital issued a press release urging the Company to answer critical questions on its Q2 2025 earnings call.
August 12, 2025Cannae's share price dropped -11% following material updates to the market.
August 13, 2025River Road Asset Management, LLC filed its Schedule 13F.
August 14, 2025Newtyn Management, LLC filed its Schedule 13F.
August 26, 2025The Company announced the Annual Meeting would be held on December 12, 2025, triggering a new nomination deadline.
September 4, 2025Carronade Capital delivered a letter to the Company re-nominating the Carronade Nominees.
September 8, 2025Carronade Capital filed amendment no. 1 to its Schedule 13D; The Vanguard Group, Inc. filed its Schedule 13G/A.
September 30, 2025Date for 51,600,000 shares of Common Stock outstanding as reported by the Company; date for 51,928,136 shares of common stock outstanding for beneficial ownership calculations.
October 17, 2025Date used for TSR and NAV discount calculations in the filing.
October 21, 2025The Company filed its preliminary proxy statement with the SEC.
October 23, 2025Carronade Capital Management, LP (Managed Account) purchased 8,840 shares of Common Stock.
October 24, 2025Carronade Capital filed amendment no. 2 to its proxy statement with the SEC.
October 28, 2025Carronade Capital filed this definitive proxy statement with the SEC.
December 11, 2025Deadline for pre-registration for the virtual Annual Meeting.
December 12, 2025Cannae's 2025 Annual Meeting of Shareholders is scheduled to be held virtually.
January 2026Beginning of period when Mr. Foley has the right to require the Company to purchase 50% of his shares.
2026 Annual MeetingClass III directors' terms expire; if Declassification Proposal approved, they will serve a one-year term.
2027 Annual MeetingClass I directors' terms expire; if Declassification Proposal approved, they and former Class III directors will serve a one-year term.
2028 Annual MeetingClass II directors' terms expire; if Declassification Proposal approved, all directors will be elected annually from this meeting onward.

Recommendation

buy

Based on Carronade Capital's definitive proxy statement, the implicit recommendation for a seasoned investor is 'buy'. Carronade, as a significant shareholder, explicitly states its belief in the 'inherent value embedded in the Companys portfolio of assets' and a 'significant opportunity for value creation' by 'unlocking the Companys trapped potential'. The entire premise of their proxy fight is that Cannae is currently undervalued due to poor governance, misaligned compensation, and ineffective strategy. If Carronade's highly qualified, independent nominees are elected and successfully implement their proposed changes (e.g., improved governance, streamlined compensation, enhanced transparency, better capital allocation), the stock is expected to appreciate significantly. Therefore, the filing presents a 'buy' opportunity for investors who believe in the activist's thesis and the potential for successful change.

Keywords

Cannae Holdings, Carronade Capital, Proxy Fight, Corporate Governance, Shareholder Activism, Board of Directors, Executive Compensation, Value Creation, Investment Management, Financial Performance, SEC Filing, DEFC14A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.